Effects of Recombinant Human Erythropoietin on Renal Function in Chronic Renal Failure Predialysis Patients-Reference-Cited by-同舟云学术

Effects of Recombinant Human Erythropoietin on Renal Function in Chronic Renal Failure Predialysis Patients

Published:1994-11 Issue:5 Volume:24 Page:777-784
ISSN:0272-6386
Container-title:American Journal of Kidney Diseases
language:en
Short-container-title:American Journal of Kidney Diseases

Author:

Roth David,Smith Ronald D.,Schulman Gerald,Steinman Theodore I.,Hatch Fred E.,Rudnick Michael R.,Sloand James A.,Freedman Barry I.,Williams Winfred W.,Shadur Craig A.,Benz Robert L.,Teehan Brendan P.,Revicki Dennis A.,Sarokhan Brenda J.,Abels Robert I.

Publisher

Elsevier BV

Subject

Nephrology

Reference26 articles.

1. Effect of recombinant human erythropoietin on renal function in humans;Lim;Kidney Int,1990

2. Treatment of the anemia of progressive renal failure with recombinant human erythropoietin;Eschbach;N Engl J Med,1989

3. Hematologic and physiologic studies during correction of anemia with recombinant human erythropoietin in predialysis patients;Teehan;Transplant Proc,1989

4. Recombinant human erythropoietin treatment in pre-dialysis patients;Lim;Ann Intern Med,1989

5. The safety and efficacy of maintenance therapy of recombinant human erythropoietin in patients with renal insufficiency;Lim;Am J Kidney Dis,1989

Cited by 160 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. What is the impact of anemia pharmacotherapy on chronic kidney disease progression?;Expert Opinion on Pharmacotherapy;2024-07-02

2. Secular Trend in GFR Decline in Non-Dialysis CKD Based on Observational Data From Standard of Care Arms of Trials;American Journal of Kidney Diseases;2023-11

3. Erythropoiesis-stimulating agents for anaemia in adults with chronic kidney disease: a network meta-analysis;Cochrane Database of Systematic Reviews;2023-02-13

4. Prevalence of anemia in patients with chronic kidney disease in Japan: A nationwide, cross-sectional cohort study using data from the Japan Chronic Kidney Disease Database (J-CKD-DB);PLOS ONE;2020-07-20

5. Pyrazolo[4,3-d]pyrimidine Derivatives as a Novel Hypoxia-Inducible Factor Prolyl Hydroxylase Domain Inhibitor for the Treatment of Anemia;ACS Medicinal Chemistry Letters;2020-06-04